OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Industry survey from Knowledgent probes management receptivity to Big Data projects
This year’s IT buzzphrase, Big Data, is getting a lot of play in media and consulting circles, even as what the phrase encompasses, and how it differs from conventional business analytics, continues to be debated. Knowledgent (New York) an IT consultancy and analytics service—with considerable skin the Big Data game—conducted an online survey to test how seriously business and IT managers in financial services, insurance and life sciences are considering the potential of Big Data, and how willing they are to commission projects around the technology. The results:
Big Data means different things to different people, and within the life sciences, it’s easy to argue that most clinical trials have been, and will increasingly become, individual Big Data projects as researchers ferret out value, or safety signals, from the datasets generated. Other researchers employ Big Data techniques to conduct basic research on genetics, biomarkers and other fundamental science. In the marketing arena, Big Data commonly encompasses gathering massive volumes of online data, from social media, search and messaging to understand market trends.
Knowledgent, which says it has a handful of projects currently under way with life sciences clients, is certainly betting on this technology. The company is also holding a meeting in Jersey City, NJ, on November 1 to bring in interested potential clients and Knowledgent business partners.